Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abiomed Inc (ABMD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,024,906
  • Shares Outstanding, K 45,086
  • Annual Sales, $ 593,750 K
  • Annual Income, $ 112,170 K
  • 60-Month Beta 0.37
  • Price/Sales 25.30
  • Price/Cash Flow 119.79
  • Price/Book 17.63

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.07
  • Number of Estimates 7
  • High Estimate 1.13
  • Low Estimate 1.03
  • Prior Year 0.80
  • Growth Rate Est. (year over year) +33.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
305.37 +11.13%
on 03/08/19
362.29 -6.33%
on 02/20/19
-20.01 (-5.57%)
since 02/19/19
3-Month
274.02 +23.84%
on 12/24/18
364.31 -6.85%
on 02/19/19
+43.22 (+14.59%)
since 12/19/18
52-Week
274.02 +23.84%
on 12/24/18
459.75 -26.19%
on 10/01/18
+51.38 (+17.84%)
since 03/19/18

Most Recent Stories

More News
Abiomed (ABMD) Gains As Market Dips: What You Should Know

Abiomed (ABMD) closed the most recent trading day at $339.28, moving +1.81% from the previous trading session.

ABMD : 339.36 (+1.83%)
Abiomed Inc Set to Possibly Pullback After Yesterday's Rally of 1.60%

Abiomed Inc (NASDAQ:ABMD) traded in a range yesterday that spanned from a low of $330.99 to a high of $338.59. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of...

ABMD : 339.36 (+1.83%)
Boston Scientific (BSX) Rides on Acquisitions, Innovation

Boston Scientific (BSX) takes a big leap forward by closing the buyout of Millipede and inking a deal to purchase BTG plc.

VAR : 136.64 (+0.79%)
ABMD : 339.36 (+1.83%)
BSX : 38.17 (+0.53%)
MASI : 133.09 (+0.63%)
Boston Scientific's EP Arm Gets a Lift From Study Success

The positive result regarding Boston Scientific's (BSX) LUMINIZE RF Balloon Catheter is expected to help the company further advance with the procedures to clinch a CE Mark for the instrument.

VAR : 136.64 (+0.79%)
ABMD : 339.36 (+1.83%)
BSX : 38.17 (+0.53%)
MASI : 133.09 (+0.63%)
Abbott's (ABT) MitraClip COAPT Trial Shows Favorable Results

The published data sets prove that Abbott's (ABT) MitraClip ensures the sustenance of long-term quality of life for patients of secondary or functional mitral regurgitation (MR).

ABT : 79.96 (+1.43%)
ABMD : 339.36 (+1.83%)
VAR : 136.64 (+0.79%)
MASI : 133.09 (+0.63%)
Here's Why You Should Invest in Integer Holdings (ITGR) Stock

Integer Holdings (ITGR) is likely to gain from the Cardio & Vascular, Neuromodulation and Non-Medical Electrochem markets.

WMGI : 32.30 (+0.44%)
ITGR : 85.94 (-0.03%)
ABMD : 339.36 (+1.83%)
IDXX : 218.30 (+1.19%)
HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4

HealthEquity (HQY) witnesses strong HSA member growth in the fourth quarter of fiscal 2019.

WMGI : 32.30 (+0.44%)
HQY : 84.51 (+1.98%)
ABMD : 339.36 (+1.83%)
IDXX : 218.30 (+1.19%)
Allscripts Partners With Opargo to Boost Practice Management

Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.

WMGI : 32.30 (+0.44%)
ABMD : 339.36 (+1.83%)
MDRX : 10.46 (+0.10%)
IDXX : 218.30 (+1.19%)
Omnicell's Global Expansion on Track, Stiff Competition Ails

Although Omnicell (OMCL) is steadily expanding in the Middle East and South African belts, it sees a greater uptake of technologies across other regions of the world.

OMCL : 84.45 (+1.37%)
VAR : 136.64 (+0.79%)
ABMD : 339.36 (+1.83%)
MASI : 133.09 (+0.63%)
Is ABIOMED (ABMD) Outperforming Other Medical Stocks This Year?

Is (ABMD) Outperforming Other Medical Stocks This Year?

ABMD : 339.36 (+1.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade ABMD with:

Business Summary

Abiomed, Inc. is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets proprietary products that are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing...

See More

Key Turning Points

2nd Resistance Point 345.73
1st Resistance Point 342.54
Last Price 339.36
1st Support Level 333.58
2nd Support Level 327.81

See More

52-Week High 459.75
Fibonacci 61.8% 388.80
Fibonacci 50% 366.89
Fibonacci 38.2% 344.97
Last Price 339.36
52-Week Low 274.02

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar